EUVIMEDEUVIMED entdecken
Crossref

Relationship Between Systemic Immune-Inflammation Index and Migraine Disability (MIDAS) in Chronic Migraine

Deniz Kamacı Şener, Özden Kamışlı

Ahi Evran Medical Journal · 29.04.2026 · 10 (1) · 88-97

DOI: 10.46332/aemj.1735273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ahi Evran Medical Journal, online erschienen am 29.04.2026. Verfasst von Deniz Kamacı Şener und 1 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Migraine is a complex neurological disease in which neuroinflammation plays a role in its pathophysiology. The Systemic Immune-Inflammation Index (SII) defined as [platelet count × neutrophil-to-lymphocyte ratio] is a parameter that can be used to indicate systemic inflammation during the course of the disease. This study aimed to investigate the relationship between systemicinflammation and migraine-related disability, assessed by the Migraine Disability Assessment Test (MIDAS), in patients with chronic migraine (CM).Materials and Methods: The study included 71 patients with chronic migraine (CM) and 63 healthy controls aged 18–60 years. Demographic characteristics, migraine attack duration, migraine disease duration, pain intensity assessed by the visual analogue scale (VAS), and migraine-related disability scores were recorded. Inflammatory parameters, including the Systemic ImmuneInflammation Index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and platelet-to-neutrophil ratio (PNR), were compared between the groups. In addition, the relationships between these inflammatory parameters and MIDAS scores, VAS scores, migraine duration, and attack duration were analyzed.

Results

In this study, lymphocyte counts were higher in patients with chronic migraine (CM), whereas haemoglobin levels were lower in patients with migraine with aura. No significant correlation was found between MIDAS scores and NLR, PLR, PNR, or SII. However, NLR and SII values were found to increase with increasing pain duration in patients with CM.

Conclusion

Although the Systemic Immune-Inflammation Index (SII) is an easily accessible and inexpensive marker of systemic inflammation, it was not associated with migraine-related disability assessed by the Migraine Disability Assessment Test (MIDAS) in patients with chronic migraine. Further large-scale and prospective studies are needed to clarify the role of SII in chronic migraine.

Zitieren

APA

Şener, D. K., & Kamışlı, Ö. (2026). Relationship Between Systemic Immune-Inflammation Index and Migraine Disability (MIDAS) in Chronic Migraine. Ahi Evran Medical Journal, 10(1), 88-97. https://doi.org/10.46332/aemj.1735273

Vancouver

Şener DK, Kamışlı Ö. Relationship Between Systemic Immune-Inflammation Index and Migraine Disability (MIDAS) in Chronic Migraine. Ahi Evran Medical Journal. 2026;10(1):88-97. doi:10.46332/aemj.1735273

BibTeX
@article{ener2026,
  author = {Şener, Deniz Kamacı and Kamışlı, Özden},
  title = {Relationship Between Systemic Immune-Inflammation Index and Migraine Disability (MIDAS) in Chronic Migraine},
  journal = {Ahi Evran Medical Journal},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {88--97},
  doi = {10.46332/aemj.1735273}
}
Kostenlos starten →